We are live on ! Find out more
IHM

Iguana Healthcare Management Portfolio holdings

AUM $152M
1-Year Est. Return 48.74%
This Fund
S&P 500
This Quarter Est. Return
+13.2%
1 Year Est. Return
+48.74%
3 Year Est. Return
+142.13%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$216M
AUM Growth
+$40.9M
Cap. Flow
+$30.7M
Cap. Flow %
14.18%
Top 10 Hldgs %
40.9%
Holding
110
New
40
Increased
20
Reduced
11
Closed
36

Top Buys

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$6.41M
2
BIIB icon
Biogen
BIIB
+$4.44M
3
CI icon
Cigna
CI
+$3.91M
4
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$3.61M
5
ALXN
Alexion Pharmaceuticals
ALXN
+$3.18M

Top Sells

Rank Stock Value
1
ARTC
ARTHROCARE CORP
ARTC
+$3.56M
2
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
+$3.4M
3
GILD icon
Gilead Sciences
GILD
+$2.74M
4
ITMN
INTERMUNE INC
ITMN
+$2.21M
5
DXCM icon
DexCom
DXCM
+$2.13M

Sector Composition

Rank Sector Weight
1 Healthcare 64.65%
2 Industrials 0.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AMGN icon
76
CALL
Amgen
AMGN
$225B
– –
-35,000
Closed -$3.96M
AMRN
77
CALL
Amarin Corp
AMRN
$299M
– –
-7,500
Closed -$291K
AXDX
78
DELISTED
Accelerate Diagnostics
AXDX
– –
-2,500
Closed -$305K
BRKR icon
79
CALL
Bruker
BRKR
$8.79B
– –
-50,000
Closed -$930K
CNMD icon
80
CONMED
CNMD
$1.49B
– –
-25,000
Closed -$1.06M
DGX icon
81
CALL
Quest Diagnostics
DGX
$26.2B
– –
-25,000
Closed -$1.52M
DXCM icon
82
DexCom
DXCM
$34B
– –
-240,000
Closed -$2.13M
ENTA icon
83
Enanta Pharmaceuticals
ENTA
$393M
– –
-40,000
Closed -$1.09M
EW icon
84
CALL
Edwards Lifesciences
EW
$53.5B
– –
-60,000
Closed -$649K
EW icon
85
Edwards Lifesciences
EW
$53.5B
– –
-150,000
Closed -$1.64M
FOLD
86
DELISTED
Amicus Therapeutics
FOLD
– –
-265,000
Closed -$623K
IWM icon
87
PUT
iShares Russell 2000 ETF
IWM
$82.1B
– –
-50,000
Closed -$5.58M
MDXG icon
88
MiMedx Group
MDXG
$627M
– –
-180,000
Closed -$1.57M
PODD icon
89
Insulet
PODD
$9.94B
– –
-25,000
Closed -$928K
SGMO
90
PUT
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
– –
-50,000
Closed -$639K
SPY icon
91
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$810B
– –
-50,000
Closed -$8.99M
SRPT icon
92
Sarepta Therapeutics
SRPT
$1.93B
– –
-70,000
Closed -$1.43M
SUPN icon
93
CALL
Supernus Pharmaceuticals
SUPN
$2.73B
– –
-100,000
Closed -$714K
UTHR icon
94
PUT
United Therapeutics
UTHR
$22.2B
– –
-15,000
Closed -$1.36M
VRTX icon
95
Vertex Pharmaceuticals
VRTX
$134B
– –
-20,000
Closed -$1.49M
CMRX
96
DELISTED
Chimerix, Inc.
CMRX
– –
-45,000
Closed -$680K
INFI
97
CALL
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
– –
-50,000
Closed -$725K
MDCO
98
PUT
DELISTED
Medicines Co
MDCO
– –
-25,000
Closed -$943K
ARRY
99
DELISTED
Array Biopharma Inc
ARRY
– –
-200,000
Closed -$1M
ESRX
100
DELISTED
Express Scripts Holding Company
ESRX
– –
-25,000
Closed -$1.76M
1 2 3
4
5

Similar funds

HWP
Hefty Wealth Partners Auburn, Indiana $155M AUM 7.56% 1-Year Est. Return
PAM
PineView Asset Management Greenwich, Connecticut $166M AUM 27.74% 1-Year Est. Return
USG2
Union Square GP 2008 New York $172M AUM
LCM
Lee Capital Management New York $132M AUM 21% 1-Year Est. Return
FPF
FNY Partners Fund New York $185M AUM 32.59% 1-Year Est. Return
FIAS
FinTrust Investment Advisory Services Greenville, South Carolina $109M AUM
CII
Chapter IV Investors Charlotte, North Carolina $109M AUM 9.21% 1-Year Est. Return
OPWM
Oak Point Wealth Management Portage, Michigan $98M AUM

Iguana Healthcare Management's Q1 2014 Portfolio in Review

As of Q1 2014, Iguana Healthcare Management held 110 positions worth $216M, up 23% from $175M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Iguana Healthcare Management deployed $30.7M of net new capital in Q1 2014, opening 40 new positions and adding to 20 existing holdings. Its largest new stake was Medtronic: 110,000 shares worth $6.77M.

By sector, the portfolio is most concentrated in Healthcare at 65% of assets, up from 61% a quarter earlier, followed by Industrials.

On the sell side, the largest reduction was Gilead Sciences, an estimated $2.74M trimmed.

  • Iguana Healthcare Management's largest Q1 2014 buy was Medtronic: 110,000 shares worth $6.77M.
  • Iguana Healthcare Management added most to Biogen in Q1 2014, an estimated $4.44M increase.
  • Iguana Healthcare Management's biggest Q1 2014 reduction was Gilead Sciences, cutting an estimated $2.74M.
  • Iguana Healthcare Management fully exited ARTHROCARE CORP in Q1 2014, selling an estimated $3.56M.
  • Iguana Healthcare Management's ten largest holdings make up 41% of its $216M portfolio in Q1 2014.
  • Iguana Healthcare Management opened 40 new positions and closed 36 in Q1 2014.
  • Iguana Healthcare Management's portfolio value rose 23% quarter-over-quarter to $216M.

Based on Iguana Healthcare Management's 13F filing for Q1 2014, filed 16 May 2014.